| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 579-591, Copyright © 1995 by Endocrine Society
ARTICLES |
D Metzger, M Berry, S Ali and P Chambon
Institut de Genetique et de Biologie Moleculaire et Cellulaire, Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale/Universite Louis Pasteur, College de France, C.U. de Strasbourg.
Functional analyses, performed with the estrogen receptor (ER) isolated from different sources or produced with various expression systems, led to contradictory results concerning the role of estrogen (E2) and antiestrogens in ER DNA binding. Here we report the DNA-binding properties of the human ER and show that the wild type ER (HEG0) binds in vitro to an estrogen response element (ERE) as a dimer, irrespective of the presence or absence of estrogen. We also show that the two antihormones, 4-hydroxytamoxifen (OHT, a partial ER agonist) and ICI 164,384 (a pure antagonist) do not impair HEG0 dimerization and DNA binding in vitro. Exposure of HEG0 to elevated temperature (37 C) in vitro results in a much faster reduction of its binding capacity to an ERE in the absence of ligand or in the presence of ICI 164,384 than in the presence of either E2 or OHT. The Gly to Val mutation at amino acid 400 present in the human ER that we initially cloned (HE0), is responsible for an even faster heat inactivation of unliganded receptor compared with HEG0 and largely accounts for the previously observed in vitro ligand-dependent DNA binding of ER. We also show that, as previously observed for OHT, ICI 164,384 does not prevent ER binding to an ERE in vivo, even though ICI 164,384 acts as a pure antagonist for transcriptional activation by ER. We discuss these results in the context of a ligand-dependent interaction between the C-terminal region E, which contains the ligand-binding domain, and the N-terminal A/B region, which contains the activation function AF-1.
This article has been cited by other articles:
![]() |
J. Ruegg, E. Swedenborg, D. Wahlstrom, A. Escande, P. Balaguer, K. Pettersson, and I. Pongratz The Transcription Factor Aryl Hydrocarbon Receptor Nuclear Translocator Functions as an Estrogen Receptor {beta}-Selective Coactivator, and Its Recruitment to Alternative Pathways Mediates Antiestrogenic Effects of Dioxin Mol. Endocrinol., February 1, 2008; 22(2): 304 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Y. X. Peh, E. Reimhult, H. F. Teh, J. S. Thomsen, and X. Su Understanding Ligand Binding Effects on the Conformation of Estrogen Receptor {alpha}-DNA Complexes: A Combinational Quartz Crystal Microbalance with Dissipation and Surface Plasmon Resonance Study Biophys. J., June 15, 2007; 92(12): 4415 - 4423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Callige, I. Kieffer, and H. Richard-Foy CSN5/Jab1 Is Involved in Ligand-Dependent Degradation of Estrogen Receptor {alpha} by the Proteasome Mol. Cell. Biol., June 1, 2005; 25(11): 4349 - 4358. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Herynk and S. A. W. Fuqua Estrogen Receptor Mutations in Human Disease Endocr. Rev., December 1, 2004; 25(6): 869 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ito, K.-i. Takeyama, A. Yamamoto, S. Sawatsubashi, Y. Shirode, A. Kouzmenko, T. Tabata, and S. Kato In vivo potentiation of human oestrogen receptor {alpha} by Cdk7-mediated phosphorylation Genes Cells, October 1, 2004; 9(10): 983 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, J. Huang, P. Yi, R. A. Bambara, R. Hilf, and M. Muyan Single-Chain Estrogen Receptors (ERs) Reveal that the ER{alpha}/{beta} Heterodimer Emulates Functions of the ER{alpha} Dimer in Genomic Estrogen Signaling Pathways Mol. Cell. Biol., September 1, 2004; 24(17): 7681 - 7694. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bai and V. Giguere Isoform-Selective Interactions between Estrogen Receptors and Steroid Receptor Coactivators Promoted by Estradiol and ErbB-2 Signaling in Living Cells Mol. Endocrinol., April 1, 2003; 17(4): 589 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Webb, P. Nguyen, and P. J. Kushner Differential SERM Effects on Corepressor Binding Dictate ERalpha Activity in Vivo J. Biol. Chem., February 21, 2003; 278(9): 6912 - 6920. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Demirpence, A. Semlali, J. Oliva, P. Balaguer, E. Badia, M.-J. Duchesne, J.-C. Nicolas, and M. Pons An Estrogen-responsive Element-targeted Histone Deacetylase Enzyme Has an Antiestrogen Activity That Differs from That of Hydroxytamoxifen Cancer Res., November 15, 2002; 62(22): 6519 - 6528. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Obrero, D. V. Yu, and D. J. Shapiro Estrogen Receptor-dependent and Estrogen Receptor-independent Pathways for Tamoxifen and 4-Hydroxytamoxifen-induced Programmed Cell Death J. Biol. Chem., November 15, 2002; 277(47): 45695 - 45703. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yi, M. D. Driscoll, J. Huang, S. Bhagat, R. Hilf, R. A. Bambara, and M. Muyan The Effects of Estrogen-Responsive Element- and Ligand-Induced Structural Changes on the Recruitment of Cofactors and Transcriptional Responses by ER{alpha} and ER{beta} Mol. Endocrinol., April 1, 2002; 16(4): 674 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Klinge, S. C. Jernigan, and K. E. Risinger The Agonist Activity of Tamoxifen Is Inhibited by the Short Heterodimer Partner Orphan Nuclear Receptor in Human Endometrial Cancer Cells Endocrinology, March 1, 2002; 143(3): 853 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Brady, M. Doubleday, L. M. Gayo-Fung, M. Hickman, S. Khammungkhune, A. Kois, S. Lipps, S. Pierce, N. Richard, G. Shevlin, et al. Differential Response of Estrogen Receptors alpha and beta to SP500263, a Novel Potent Selective Estrogen Receptor Modulator Mol. Pharmacol., March 1, 2002; 61(3): 562 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Fannon, R. M. Vidaver, and S. A. Marts Genome and Hormones: Gender Differences in Physiology: Historical Perspectives: An abridged history of sex steroid hormone receptor action J Appl Physiol, October 1, 2001; 91(4): 1854 - 1859. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Feng, P. Webb, P. Nguyen, X. Liu, J. Li, M. Karin, and P. J. Kushner Potentiation of Estrogen Receptor Activation Function 1 (AF-1) by Src/JNK through a Serine 118-Independent Pathway Mol. Endocrinol., January 1, 2001; 15(1): 32 - 45. [Abstract] [Full Text] |
||||
![]() |
R. A. Shapiro, C. Xu, and D. M. Dorsa Differential Transcriptional Regulation of Rat Vasopressin Gene Expression by Estrogen Receptor {alpha} and {beta} Endocrinology, November 1, 2000; 141(11): 4056 - 4064. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dowsett, J. M. Dixon, K. Horgan, J. Salter, M. Hills, and E. Harvey Antiproliferative Effects of Idoxifene in a Placebo-controlled Trial in Primary Human Breast Cancer Clin. Cancer Res., June 1, 2000; 6(6): 2260 - 2267. [Abstract] [Full Text] |
||||
![]() |
G. de Haan, S. Chusacultanachai, C. Mao, B. S. Katzenellenbogen, and D. J. Shapiro Estrogen Receptor-KRAB Chimeras Are Potent Ligand-dependent Repressors of Estrogen-regulated Gene Expression J. Biol. Chem., April 28, 2000; 275(18): 13493 - 13501. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Zhang, S. Krieg, and D. J. Shapiro HMG-1 Stimulates Estrogen Response Element Binding by Estrogen Receptor from Stably Transfected HeLa Cells Mol. Endocrinol., April 1, 1999; 13(4): 632 - 643. [Abstract] [Full Text] |
||||
![]() |
D. Chen, P. E. Pace, R. C. Coombes, and S. Ali Phosphorylation of Human Estrogen Receptor alpha by Protein Kinase A Regulates Dimerization Mol. Cell. Biol., February 1, 1999; 19(2): 1002 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsai-Pflugfelder, S. M. Gasser, and W. Wahli Functional Interaction between the Estrogen Receptor and CTF1: Analysis of the Vitellogenin Gene B1 Promoter in Yeast Mol. Endocrinol., October 1, 1998; 12(10): 1525 - 1541. [Abstract] [Full Text] |
||||
![]() |
A. Barsalou, W. Gao, S. I. Anghel, J. Carriere, and S. Mader Estrogen Response Elements Can Mediate Agonist Activity of Anti-estrogens in Human Endometrial Ishikawa Cells J. Biol. Chem., July 3, 1998; 273(27): 17138 - 17146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Devin-Leclerc, X. Meng, F. Delahaye, P. Leclerc, E.-E. Baulieu, and M.-G. Catelli Interaction and Dissociation by Ligands of Estrogen Receptor and Hsp90: The Antiestrogen RU 58668 Induces a Protein Synthesis-Dependent Clustering of the Receptor in the Cytoplasm Mol. Endocrinol., June 1, 1998; 12(6): 842 - 854. [Abstract] [Full Text] |
||||
![]() |
E. K. Gass, S. A. Leonhardt, S. K. Nordeen, and D. P. Edwards The Antagonists RU486 and ZK98299 Stimulate Progesterone Receptor Binding to Deoxyribonucleic Acid in Vitro and in Vivo, but Have Distinct Effects on Receptor Conformation Endocrinology, April 1, 1998; 139(4): 1905 - 1919. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Kraus and J. T. Kadonaga p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation Genes & Dev., February 1, 1998; 12(3): 331 - 342. [Abstract] [Full Text] |
||||
![]() |
C. A. Powers, M. Mathur, B. M. Raaka, D. Ron, and H. H. Samuels TLS (Translocated-in-Liposarcoma) Is a High-Affinity Interactor for Steroid, Thyroid Hormone, and Retinoid Receptors Mol. Endocrinol., January 1, 1998; 12(1): 4 - 18. [Abstract] [Full Text] |
||||
![]() |
A. Tremblay, G. B. Tremblay, C. Labrie, F. Labrie, and V. Giguere EM-800, a Novel Antiestrogen, Acts as a Pure Antagonist of the Transcriptional Functions of Estrogen Receptors {alpha} and {beta} Endocrinology, January 1, 1998; 139(1): 111 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Melamed, E. Castaño, A. C. Notides, and S. Sasson Molecular and Kinetic Basis for the Mixed Agonist/Antagonist Activity of Estriol Mol. Endocrinol., November 1, 1997; 11(12): 1868 - 1878. [Abstract] [Full Text] |
||||
![]() |
P. Pace, J. Taylor, S. Suntharalingam, R. C. Coombes, and S. Ali Human Estrogen Receptor beta Binds DNA in a Manner Similar to and Dimerizes with Estrogen Receptor alpha J. Biol. Chem., October 10, 1997; 272(41): 25832 - 25838. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Cowley, S. Hoare, S. Mosselman, and M. G. Parker Estrogen Receptors alpha and beta Form Heterodimers on DNA J. Biol. Chem., August 8, 1997; 272(32): 19858 - 19862. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. K. El-Tanani and C. D. Green Two Separate Mechanisms for Ligand-Independent Activation of the Estrogen Receptor Mol. Endocrinol., June 1, 1997; 11(7): 928 - 937. [Abstract] [Full Text] |
||||
![]() |
S. Thenot, C. Henriquet, H. Rochefort, and V. Cavailles Differential Interaction of Nuclear Receptors with the Putative Human Transcriptional Coactivator hTIF1 J. Biol. Chem., May 2, 1997; 272(18): 12062 - 12068. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Aumais, H. S. Lee, R. Lin, and J. H. White Selective Interaction of hsp90 with an Estrogen Receptor Ligand-binding Domain Containing a Point Mutation J. Biol. Chem., May 2, 1997; 272(18): 12229 - 12235. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. P. Bocchinfuso and K. S. Korach Estrogen Receptor Residues Required for Stereospecific Ligand Recognition and Activation Mol. Endocrinol., May 1, 1997; 11(5): 587 - 594. [Abstract] [Full Text] |
||||
![]() |
B. J. Cheskis, S. Karathanasis, and C. R. Lyttle Estrogen Receptor Ligands Modulate Its Interaction with DNA J. Biol. Chem., April 25, 1997; 272(17): 11384 - 11391. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Dipippo and C. A. Powers Tamoxifen and ICI 182,780 Interactions with Thyroid Hormone in the Ovariectomized-Thyroidectomized Rat J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 142 - 148. [Abstract] [Full Text] |
||||
![]() |
G. B. Tremblay, A. Tremblay, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, F. Labrie, and V. Giguère Cloning, Chromosomal Localization, and Functional Analysis of the Murine Estrogen Receptor {beta} Mol. Endocrinol., March 1, 1997; 11(3): 353 - 365. [Abstract] [Full Text] |
||||
![]() |
Y. Lee and J. Gorski Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy PNAS, December 24, 1996; 93(26): 15180 - 15184. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Lee, J. Aumais, and J. H. White Hormone-dependent Transactivation by Estrogen Receptor Chimeras That Do Not Interact with hsp90. EVIDENCE FOR TRANSCRIPTIONAL REPRESSORS J. Biol. Chem., October 18, 1996; 271(42): 25727 - 25730. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kato, H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, et al. Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase Science, December 1, 1995; 270(5241): 1491 - 1494. [Abstract] [PDF] |
||||
![]() |
C. Teyssier, K. Belguise, F. Galtier, and D. Chalbos Characterization of the Physical Interaction between Estrogen Receptor alpha and JUN Proteins J. Biol. Chem., September 21, 2001; 276(39): 36361 - 36369. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |